SFG
COLL icon

Steward Financial Group’s Collegium Pharmaceutical COLL Stock Holding History

Steward Financial Group’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$0 Buy
+37
New +$844 ﹤0.01% 1364
2023
Q2 		– Sell
-37
Closed – – 575
2023
Q1 		$0 Buy
+37
New +$981 ﹤0.01% 756

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Steward Financial Group's COLL Position: Q3 2023 in Review

Steward Financial Group opened a new position in Collegium Pharmaceutical (COLL) in Q3 2023: 37 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1364 among its holdings. This is a return to the name: Steward Financial Group previously reported a position in COLL as recently as Q1 2023.

Steward Financial Group first reported a position in COLL in Q1 2023 and has held it in 2 quarters since. 174 funds tracked by Wall St. Rank hold COLL as of Q3 2023.

  • Steward Financial Group held 37 shares of Collegium Pharmaceutical worth $0 as of Q3 2023.
  • Collegium Pharmaceutical was a new Steward Financial Group position in Q3 2023.
  • Collegium Pharmaceutical made up ﹤0.01% of Steward Financial Group's portfolio in Q3 2023, its #1364 holding.
  • Steward Financial Group first reported a position in Collegium Pharmaceutical in Q1 2023 and has held it in 2 quarters since.
  • 174 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.